[go: up one dir, main page]

EP1863770A4 - CYCLE CLOSURE AND ASSOCIATED METHODS AND INTERMEDIATE PRODUCTS - Google Patents

CYCLE CLOSURE AND ASSOCIATED METHODS AND INTERMEDIATE PRODUCTS

Info

Publication number
EP1863770A4
EP1863770A4 EP06769789A EP06769789A EP1863770A4 EP 1863770 A4 EP1863770 A4 EP 1863770A4 EP 06769789 A EP06769789 A EP 06769789A EP 06769789 A EP06769789 A EP 06769789A EP 1863770 A4 EP1863770 A4 EP 1863770A4
Authority
EP
European Patent Office
Prior art keywords
intermediate products
associated methods
cycle closure
closure
cycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06769789A
Other languages
German (de)
French (fr)
Other versions
EP1863770A2 (en
Inventor
David S Hays
Sonja S Mackey
William H Moser
Doris Stoermer
Matthew R Radmer
Shri Niwas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
Coley Pharmaceutical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coley Pharmaceutical Group Inc filed Critical Coley Pharmaceutical Group Inc
Publication of EP1863770A2 publication Critical patent/EP1863770A2/en
Publication of EP1863770A4 publication Critical patent/EP1863770A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EP06769789A 2005-04-01 2006-03-31 CYCLE CLOSURE AND ASSOCIATED METHODS AND INTERMEDIATE PRODUCTS Withdrawn EP1863770A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66784005P 2005-04-01 2005-04-01
PCT/US2006/012022 WO2006121528A2 (en) 2005-04-01 2006-03-31 Ring closing and related methods and intermediates

Publications (2)

Publication Number Publication Date
EP1863770A2 EP1863770A2 (en) 2007-12-12
EP1863770A4 true EP1863770A4 (en) 2010-05-05

Family

ID=37397032

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06769789A Withdrawn EP1863770A4 (en) 2005-04-01 2006-03-31 CYCLE CLOSURE AND ASSOCIATED METHODS AND INTERMEDIATE PRODUCTS

Country Status (6)

Country Link
US (1) US8168802B2 (en)
EP (1) EP1863770A4 (en)
JP (1) JP2008535831A (en)
AU (1) AU2006244635A1 (en)
CA (1) CA2602853A1 (en)
WO (1) WO2006121528A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
AR045260A1 (en) 2003-08-12 2005-10-19 3M Innovative Properties Co COMPOUNDS CONTAINING IMIDAZO-OXIMA REPLACED
RU2006105101A (en) 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Aryloxy and arylalkylene-substituted substituted imidazoquinolines
US20050054665A1 (en) 2003-09-05 2005-03-10 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
BRPI0414856A (en) 2003-10-03 2006-11-21 3M Innovative Properties Co alkoxy-substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
KR101494056B1 (en) 2003-10-03 2015-02-16 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Pyrazolopyridines and analogs thereof
JP2007511535A (en) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー Hydroxylamine substituted imidazo ring compounds
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
EP1687307B1 (en) 2003-11-25 2016-01-06 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7579359B2 (en) 2004-09-02 2009-08-25 3M Innovative Properties Company 1-alkoxy 1H-imidazo ring systems and methods
ES2392648T3 (en) 2004-12-30 2012-12-12 3M Innovative Properties Company Substituted chiral compounds containing a condensed 1,2-imidazo-4,5-c core
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
ES2475728T3 (en) 2005-02-09 2014-07-11 3M Innovative Properties Company Thiazoloquinolines and alkoxy substituted thiazolonaphthyridines
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
WO2006091647A2 (en) 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Method of preferentially inducing the biosynthesis of interferon
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
JP5247458B2 (en) * 2005-11-04 2013-07-24 スリーエム・イノベイティブ・プロパティーズ・カンパニー Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods
WO2007100634A2 (en) 2006-02-22 2007-09-07 3M Innovative Properties Company Immune response modifier conjugates
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
BR112013003772A2 (en) 2010-08-17 2016-08-02 3M Innovative Properties Co lipid immune response modifying compound compositions, formulations and methods
JP6460789B2 (en) 2011-06-03 2019-01-30 スリーエム イノベイティブ プロパティズ カンパニー Heterobifunctional linker having polyethylene glycol segment and immune response modulating complex prepared from the linker
EP2718292B1 (en) 2011-06-03 2018-03-14 3M Innovative Properties Company Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
JP5935123B2 (en) * 2011-08-22 2016-06-15 国立研究開発法人産業技術総合研究所 High temperature high pressure cross coupling method
ES2538880B1 (en) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. A procedure to obtain 4-amino-1-isobutyl-1H-imidazo [4,5-c] quinolein
EP3344622B1 (en) 2015-08-31 2021-07-07 3M Innovative Properties Company Guanidine substituted, fused 1h-imidazo[4,5-c]pyridine compounds useful in the treatment of viral and neoplastic diseases
CN107922416B (en) * 2015-08-31 2021-07-02 3M创新有限公司 Imidazo [4,5-c ] ring compounds containing substituted guanidine groups
WO2017046675A1 (en) * 2015-09-14 2017-03-23 Pfizer Inc. Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors
WO2018160552A1 (en) 2017-03-01 2018-09-07 3M Innovative Properties Company IMIDAZO[4,5-c] RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS
JP7197244B2 (en) 2017-12-20 2022-12-27 スリーエム イノベイティブ プロパティズ カンパニー Amido-substituted imidazo[4,5-C]quinoline compounds with branched chain linking groups for use as immune response modifiers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0645389A1 (en) * 1993-09-17 1995-03-29 Lonza A.G. Process for the production of imidazopyridines
EP1256582A1 (en) * 2000-02-09 2002-11-13 Hokuriku Seiyaku Co., Ltd. 1h-imidazopyridine derivatives
US20040204436A1 (en) * 1997-12-11 2004-10-14 Gerster John F. Imidazonaphthyridines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645976A1 (en) 1966-06-18 1971-01-21 Ajinomoto Kk Process for the preparation of adenosine and 2 ', 3'-O-isopropylidene adenosine
US4420617A (en) 1980-03-28 1983-12-13 Sterling Drug Inc. 5(Pyridinyl)pyridin-2-amines
DE3723070A1 (en) * 1987-07-11 1989-01-19 Bayer Ag METHOD FOR PRODUCING SUBSTITUTED PYRIDYL ALKYL KETONES
WO2001046190A1 (en) * 1999-12-22 2001-06-28 Kyorin Pharmaceutical Co., Ltd. Tricyclic compounds and addition salts thereof
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0645389A1 (en) * 1993-09-17 1995-03-29 Lonza A.G. Process for the production of imidazopyridines
US20040204436A1 (en) * 1997-12-11 2004-10-14 Gerster John F. Imidazonaphthyridines
EP1256582A1 (en) * 2000-02-09 2002-11-13 Hokuriku Seiyaku Co., Ltd. 1h-imidazopyridine derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HOFFMAN J M ET AL: "Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.", JOURNAL OF MEDICINAL CHEMISTRY FEB 1983, vol. 26, no. 2, February 1983 (1983-02-01), pages 140 - 144, XP002575213, ISSN: 0022-2623 *

Also Published As

Publication number Publication date
WO2006121528A3 (en) 2007-09-13
EP1863770A2 (en) 2007-12-12
US20110269965A1 (en) 2011-11-03
JP2008535831A (en) 2008-09-04
CA2602853A1 (en) 2006-11-16
WO2006121528A2 (en) 2006-11-16
AU2006244635A1 (en) 2006-11-16
US8168802B2 (en) 2012-05-01

Similar Documents

Publication Publication Date Title
EP1863770A4 (en) CYCLE CLOSURE AND ASSOCIATED METHODS AND INTERMEDIATE PRODUCTS
ATE463480T1 (en) PROCESS AND INTERMEDIATE PRODUCTS
EP1954244A4 (en) Lyophilization process and products obtained thereby
GB0811117D0 (en) Pathogen-controlling products
BRPI0716946B8 (en) cereal cooking product
EP1895853A4 (en) Yogurt-cheese products and methods for making the same
BRPI0914354A2 (en) "methods and articles"
GB0812933D0 (en) Novel products and method
EP1870177A4 (en) CLOSING PROCESS AND CLOSURE MACHINE
EP1870175A4 (en) CLOSING PROCESS AND CLOSURE MACHINE
ZA200902899B (en) Product and process
IL192342A0 (en) Product and process
EP1867406A4 (en) CLOSING PROCESS AND CLOSURE MACHINE
FR2885345B1 (en) CYCLE FRAME
EP1867407A4 (en) CLOSING PROCESS AND CLOSURE MACHINE
EP1867405A4 (en) CLOSING PROCESS AND CLOSURE MACHINE
ZA200805267B (en) Pathogen-controlling products
GB0613826D0 (en) Process and product
GB0518777D0 (en) Products and methods
ATE374761T1 (en) SYNTHESIS PROCESS AND BENZOXATHIE INTERMEDIATE PRODUCTS
GB2430345B (en) Improvements in or relating to snack products
ES1063079Y (en) CLOSURE FOR JEWELRY AND JEWELRY ITEMS
ATE383087T1 (en) Spreadable meat product
GB0514009D0 (en) Article and method
GB0513997D0 (en) Article and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071009

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100408

17Q First examination report despatched

Effective date: 20100706

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: 3M INNOVATIVE PROPERTIES COMPANY

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131001